Onconetix, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-57.4% -$408K
$304K
Cost of Revenue↑+7.5% +$4K
$56K
Gross Profit↓-62.5% -$412K
$248K
R&D↓-50.1% -$25K
$24K
SG&A↓-42.8% -$1M
$2M
D&A↓-97.2% -$116K
$3K
Operating Income↑+21.8% +$577K
$-2M
EBITDA↓-97.2% -$116K
$3K
Interest Expense↓-98.3% -$244K
$4K
Other Income/Expense↓-537.4% -$5M
$-6M
Pretax Income↓-126.2% -$5M
$-9M
Tax Provision↓-84.2% -$303K
$57K
Net Income↓-129.5% -$5M
$-9M
Gross Margin↓-11.1pts
81.6%
Operating Margin↓-31.1pts
-681.5%
Net Margin↓-1952.0pts
-2892.7%
Effective Tax Rate↓-1.5pts
-0.0%
Deferred Tax Liabilities
$62K
ETR (Continuing Operations)
—
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-3.2pts
-2.6%
ETR Foreign Differential (pp)↓-0.1pts
-0.1%
Operating Lease Cost
—
Pension Net Periodic Cost↓-1116.2% -$467K
$-425K
Revenue YoY Variation
-57.4%
Income YoY Variation↓-19.3pts
21.8%
Revenue QoQ Variation↓-75.0pts
-0.0%
Income QoQ Variation↓-87.5pts
-6.9%